PATENT CLAIM ANALYSIS

Application Number: 15862011
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "314000"]

Abstract:
The present invention includes a method of reducing or inhibiting the kinase activity of C-KIT mutant tyrosine kinase activity in a cell or a subject, and the use of such compound for treating mutant C-KIT driven cell proliferative disorder(s) in a subject related to using a compound of the present invention: or pharmaceutically acceptable salt thereof.

Claim (Index 3):
The method of  claim 1 , wherein the therapeutically effective amounts are from about 15 to 500, 25 to 450, 50 to 400, 100 to 350, 150 to 300, 200 to 250, 15, 25, 50, 75, 100, 150, 200, 250, 300, 400, 450, or 500 mg per day.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.5122
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15255912', '14026886', '14026778', '14671613', '10579586']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8263967489056158
- 35 USC 102 Novelty (BERT): 0.6613923131410565
- Combined Prediction Score: 0.8098963053291599
- Mean Citation Score: 486.59087199999993
- Max Citation Score: 648.9252299999997
- Similarity Product: 629.4089882527934

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test